PMID- 21630378 OWN - NLM STAT- MEDLINE DCOM- 20111115 LR - 20220330 IS - 1549-4918 (Electronic) IS - 1066-5099 (Print) IS - 1066-5099 (Linking) VI - 29 IP - 8 DP - 2011 Aug TI - Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. PG - 1294-303 LID - 10.1002/stem.667 [doi] AB - Chronic pain conditions are difficult to treat and are major health problems. Bone marrow stromal cells (BMSCs) have generated considerable interest as a candidate for cell-based therapy. BMSCs are readily accessible and are easy to isolate and expand ex vivo. Clinical studies show that direct injection of BMSCs does not produce unwanted side effects and is well tolerated and safe. Here, we show that a single systemic (intravenous) or local injection (into the lesion site) of rat primary BMSCs reversed pain hypersensitivity in rats after injury and that the effect lasted until the conclusion of the study at 22 weeks. The pain hypersensitivity was rekindled by naloxone hydrochloride, an opioid receptor antagonist that acts peripherally and centrally, when tested at 1-5 weeks after BMSC infusion. In contrast, naloxone methiodide, a peripherally acting opioid receptor antagonist, only rekindled hyperalgesia in the first 3 weeks of BMSC treatment. Focal downregulation of brainstem mu opioid receptors by RNA interference (RNAi) reversed the effect of BMSCs, when RNAi was introduced at 5- but not 1-week after BMSC transplantation. Thus, BMSCs produced long-term relief of pain and this effect involved activation of peripheral and central opioid receptors in distinct time domains. The findings prompt studies to elucidate the cellular mechanisms of the BMSC-induced pain relieving effect and translate these observations into clinical settings. CI - Copyright (c) 2011 AlphaMed Press. FAU - Guo, Wei AU - Guo W AD - Department of Neural and Pain Sciences, Dental School, University of Maryland, Baltimore, Maryland 21201-1586, USA. FAU - Wang, Hu AU - Wang H FAU - Zou, Shiping AU - Zou S FAU - Gu, Ming AU - Gu M FAU - Watanabe, Mineo AU - Watanabe M FAU - Wei, Feng AU - Wei F FAU - Dubner, Ronald AU - Dubner R FAU - Huang, George T-J AU - Huang GT FAU - Ren, Ke AU - Ren K LA - eng GR - NS059028/NS/NINDS NIH HHS/United States GR - R01 DE019156-05/DE/NIDCR NIH HHS/United States GR - R01 DE011964/DE/NIDCR NIH HHS/United States GR - DE018573/DE/NIDCR NIH HHS/United States GR - R01 NS059028/NS/NINDS NIH HHS/United States GR - R01 NS060735/NS/NINDS NIH HHS/United States GR - DE11964/DE/NIDCR NIH HHS/United States GR - R01 DE018573/DE/NIDCR NIH HHS/United States GR - NS060735/NS/NINDS NIH HHS/United States GR - R01 DE019156/DE/NIDCR NIH HHS/United States GR - DE019156/DE/NIDCR NIH HHS/United States GR - R01 DE019156-03/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - England TA - Stem Cells JT - Stem cells (Dayton, Ohio) JID - 9304532 RN - 0 (Antigens, CD) RN - 0 (Narcotic Antagonists) RN - 0 (Receptors, Opioid, mu) RN - 36B82AMQ7N (Naloxone) SB - IM MH - Animals MH - Antigens, CD/metabolism MH - Bone Marrow Cells/metabolism MH - *Bone Marrow Transplantation MH - Cell Shape MH - Male MH - *Mesenchymal Stem Cell Transplantation MH - Mesenchymal Stem Cells/metabolism MH - Myelencephalon/metabolism MH - Naloxone/pharmacology MH - Narcotic Antagonists/pharmacology MH - *Pain Management MH - RNA Interference MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Opioid, mu/genetics/metabolism MH - Stromal Cells/metabolism/*transplantation MH - Tendon Injuries/therapy PMC - PMC3277433 MID - NIHMS331028 COIS- Disclosure of Potential Conflicts of Interest The authors indicate no potential conflicts of interest. EDAT- 2011/06/02 06:00 MHDA- 2011/11/16 06:00 PMCR- 2012/02/10 CRDT- 2011/06/02 06:00 PHST- 2011/06/02 06:00 [entrez] PHST- 2011/06/02 06:00 [pubmed] PHST- 2011/11/16 06:00 [medline] PHST- 2012/02/10 00:00 [pmc-release] AID - 10.1002/stem.667 [doi] PST - ppublish SO - Stem Cells. 2011 Aug;29(8):1294-303. doi: 10.1002/stem.667.